Literature DB >> 1331345

Quality of life in patients with intracranial tumors on the basis of Karnofsky's performance status.

W Sachsenheimer1, W Piotrowski, T Bimmler.   

Abstract

This prospective clinical trial (1983-1989) compares life-quality scores according to Karnofsky in patients with intra-cranial who had been operated upon. Karnofsky's performance status was evaluated during a follow-up period of 36 months. The patients were between 20 to 77 years of age; 132 patients had an astrocytoma grade III or IV; 42 patients with brain metastases were investigated; 72 had an astrocytoma grade I + II, and 144 had a meningioma. The median survival in patients with astrocytomas grade III or IV was 12 months; a short period with nearly normal activity (Karnofsky score 75) was followed by rapid deterioration. In patients with brain metastases, postoperatively the median functional ability reached its highest value three weeks after treatment and then decreased continuously (average score from 50-25). In patients with astrocytomas grade I and II, life-quality was reasonably good (mean score up to 75). The score was observed to increase slightly during the first year after treatment. A performance status improvement up to 80 could be obtained in patients with meningiomas; however, 35% were left unfit for work.

Entities:  

Mesh:

Year:  1992        PMID: 1331345     DOI: 10.1007/bf00172768

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  13 in total

1.  Supratentorial anaplastic gliomas in adults. The prognostic importance of extent of resection and prior low-grade glioma.

Authors:  M J Winger; D R Macdonald; J G Cairncross
Journal:  J Neurosurg       Date:  1989-10       Impact factor: 5.115

2.  [Neuropsychiatric and psychological test investigations after meningioma operations].

Authors:  P A Fischer; G Schmidt; K Wanke; U Petersen
Journal:  Fortschr Neurol Psychiatr Grenzgeb       Date:  1968-01

Review 3.  Measuring and analysing quality of life in cancer clinical trials: a review.

Authors:  P M Fayers; D R Jones
Journal:  Stat Med       Date:  1983 Oct-Dec       Impact factor: 2.373

4.  A lesson from Canada: Ontario's health insurance.

Authors:  E Frei; A L Frechette
Journal:  N Engl J Med       Date:  1978-03-09       Impact factor: 91.245

5.  Histologic and non-histologic factors correlated with survival time in supratentorial astrocytic tumors.

Authors:  F Cohadon; N Aouad; A Rougier; C Vital; J Rivel; J F Dartigues
Journal:  J Neurooncol       Date:  1985       Impact factor: 4.130

6.  The nature of suffering and the goals of medicine.

Authors:  E J Cassel
Journal:  N Engl J Med       Date:  1982-03-18       Impact factor: 91.245

7.  Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications.

Authors:  P C Burger; F S Vogel; S B Green; T A Strike
Journal:  Cancer       Date:  1985-09-01       Impact factor: 6.860

8.  Quality of survival of patients with brain gliomas treated with postoperative CCNU and radiation therapy.

Authors:  T Trojanowski; J Peszyński; K Turowski; P Markiewicz; I Gościński; A Bielawski; B Bendarzewska; J Szymona; A Dabrowska; J Lopatkiewicz
Journal:  J Neurosurg       Date:  1989-01       Impact factor: 5.115

9.  Survival and prognosis of patients with astrocytoma with atypical or anaplastic features.

Authors:  D F Nelson; J S Nelson; D R Davis; C H Chang; T W Griffin; T F Pajak
Journal:  J Neurooncol       Date:  1985       Impact factor: 4.130

10.  The value of radiation therapy in addition to surgery for astrocytomas of the adult cerebrum.

Authors:  D M Garcia; K H Fulling; J E Marks
Journal:  Cancer       Date:  1985-03-01       Impact factor: 6.860

View more
  18 in total

Review 1.  Review on quality of life issues in patients with primary brain tumors.

Authors:  Martin J B Taphoorn; Eefje M Sizoo; Andrew Bottomley
Journal:  Oncologist       Date:  2010-05-27

2.  The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires.

Authors:  D Osoba; N K Aaronson; M Muller; K Sneeuw; M A Hsu; W K Yung; M Brada; E Newlands
Journal:  Qual Life Res       Date:  1996-02       Impact factor: 4.147

3.  Recurrent brain tumour: the impact of illness on patient's life.

Authors:  Elena Lamperti; Giuseppe Pantaleo; Claudia Yvonne Finocchiaro; Antonio Silvani; Andrea Botturi; Paola Gaviani; Lucio Sarno; Andrea Salmaggi
Journal:  Support Care Cancer       Date:  2011-07-03       Impact factor: 3.603

4.  Quality of life following surgery for intracranial meningiomas at Brigham and Women's Hospital: a study of 164 patients using a modification of the functional assessment of cancer therapy-brain questionnaire.

Authors:  S N Kalkanis; A Quiñones-Hinojosa; E Buzney; H J Ribaudo; P M Black
Journal:  J Neurooncol       Date:  2000-07       Impact factor: 4.130

Review 5.  Contemporary surgical outcome for skull base meningiomas.

Authors:  Chien-Min Chen; Abel Po-Hao Huang; Lu-Ting Kuo; Yong-Kwang Tu
Journal:  Neurosurg Rev       Date:  2011-05-26       Impact factor: 3.042

6.  Quantitative measurement of quality outcome in malignant glioma patients using an independent living score (ILS). Assessment of a retrospective cohort.

Authors:  L Recht; M Glantz; M Chamberlain; C C Hsieh
Journal:  J Neurooncol       Date:  2003-01       Impact factor: 4.130

7.  Acquired Personality Disturbances After Meningioma Resection Are Strongly Associated With Impaired Quality of Life.

Authors:  Joseph Barrash; Taylor J Abel; Katrina L Okerstrom-Jezewski; Mario Zanaty; Joel E Bruss; Kenneth Manzel; Matthew Howard; Daniel Tranel
Journal:  Neurosurgery       Date:  2020-08-01       Impact factor: 4.654

Review 8.  FACT-MNG: tumor site specific web-based outcome instrument for meningioma patients.

Authors:  D Zlotnick; S N Kalkanis; A Quinones-Hinojosa; K Chung; M E Linskey; R L Jensen; F DeMonte; F G Barker; C A Racine; M S Berger; P M Black; M Cusimano; L N Sekhar; A Parsa; M Aghi; Michael W McDermott
Journal:  J Neurooncol       Date:  2010-09-18       Impact factor: 4.130

9.  The association between four SNPs of X-ray repair cross complementing protein 1 and the sensitivity to radiotherapy in patients with esophageal squamous cell carcinoma.

Authors:  Yaohong Zhang; Zhaoyun Luo; Liye Yang; Senming Chen; Chuzhi Chen; Zhixiong Lin
Journal:  Oncol Lett       Date:  2016-03-29       Impact factor: 2.967

10.  Conductive interstitial hyperthermia in the treatment of intracranial metastatic disease.

Authors:  C J Moran; J A Marchosky; F J Wippold; J A DeFord; N E Fearnot
Journal:  J Neurooncol       Date:  1995-10       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.